[1] |
HU WY, RAO CY, LIU HB, et al. A case of spontaneous portosystemic shunt with hepatic encephalopathy[J]. J Clin Hepatol, 2019, 35(3): 611-612. DOI: 10.3969/j.issn.1001-5256.2019.03.033.
|
[2] |
PAQUET KJ. Causes and pathomechanisms of oesophageal varices development[J]. Med Sci Monit, 2000, 6(5): 915-928.
|
[3] |
SHIGEFUKU R, IWASA M, EGUCHI A, et al. Serum copeptin level is a biomarker associated with ascites retention and the formation of a portosystemic shunt in chronic liver disease[J]. J Gastroenterol Hepatol, 2021, 36(4): 1006-1014. DOI: 10.1111/jgh.15215.
|
[4] |
TANG SH, ZENG WZ, WU XL, et al. Formation of collateral circulation in patients with cirrhotic portal hypertension and its clinical significance[J]. J Clin Hepatol, 2016, 32(8): 1613-1616. DOI: 10.3969/j.issn.1001-5256.2016.08.043.
|
[5] |
WU Q, SHEN L, CHU J, et al. Characterization of uncommon portosystemic collateral circulations in patients with hepatic cirrhosis[J]. Oncol Lett, 2015, 9(1): 347-350. DOI: 10.3892/ol.2014.2626.
|
[6] |
BANDALI MF, MIRAKHUR A, LEE EW, et al. Portal hypertension: Imaging of portosystemic collateral pathways and associated image-guided therapy[J]. World J Gastroenterol, 2017, 23(10): 1735-1746. DOI: 10.3748/wjg.v23.i10.1735.
|
[7] |
ARORA A, RAJESH S, MEENAKSHI YS, et al. Spectrum of hepatofugal collateral pathways in portal hypertension: An illustrated radiological review[J]. Insights Imaging, 2015, 6(5): 559-572. DOI: 10.1007/s13244-015-0419-8.
|
[8] |
MITTY HA, COHEN BA, SPRAYREGEN S, et al. Adrenal pseudotumors on CT due to dilated portosystemic veins[J]. AJR Am J Roentgenol, 1983, 141(4): 727-730. DOI: 10.2214/ajr.141.4.727.
|
[9] |
GOULD HR, BENJAMIN S, ALTER AJ, et al. Retroperitoneal varices simulating masses[J]. Gastrointest Radiol, 1982, 7(4): 335-339. DOI: 10.1007/BF01887667.
|
[10] |
ZONG R, YANG JY, SONG JY, et al. Multi-slice CT portal venography in demonstrating collateral circulation of portal hypertension[J]. J Chin Clin Med Imaging, 2013, 24(10): 747-749. DOI: 10.3969/j.issn.1008-1062.2013.10.020.
|
[11] |
WACHSBERG RH, YAGHMAI V, JAVORS BR, et al. Cardiophrenic varices in portal hypertension: Evaluation with CT[J]. Radiology, 1995, 195(2): 553-556. DOI: 10.1148/radiology.195.2.7724782.
|
[12] |
SIMÓN-TALERO M, ROCCARINA D, MARTÍNEZ J, et al. Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis[J]. Gastroenterology, 2018, 154(6): 1694-1705. e4. DOI: 10.1053/j.gastro.2018.01.028.
|
[13] |
ALLARD MA, AKAMATSU N, KOKUDO T, et al. Clinical significance of spontaneous portosystemic shunts in living donor liver transplanta tion[J]. Liver Transpl, 2021, 27(1): 77-87. DOI: 10.1002/lt.25798.
|
[14] |
WACHSBERG RH, BAHRAMIPOUR P, SOFOCLEOUS CT, et al. Hepatofugal flow in the portal venous system: Pathophysiology, imaging findings, and diagnostic pitfalls[J]. Radiographics, 2002, 22(1): 123-140. DOI: 10.1148/radiographics.22.1.g02ja20123.
|
[15] |
SUBRAMANYAM BR, BALTHAZAR EJ, MADAMBA MR, et al. Sonography of portosystemic venous collaterals in portal hypertension[J]. Radiology, 1983, 146(1): 161-166. DOI: 10.1148/radiology.146.1.6849040.
|
[16] |
SALAHSHOUR F, MEHRABINEJAD MM, RASHIDI SHAHPASANDI MH, et al. Esophageal variceal hemorrhage: The role of MDCT characteristics in predicting the presence of varices and bleeding risk[J]. Abdom Radiol (NY), 2020, 45(8): 2305-2314. DOI: 10.1007/s00261-020-02585-5.
|
[17] |
BERZIGOTTI A, SEIJO S, REVERTER E, et al. Assessing portal hypertension in liver diseases[J]. Expert Rev Gastroenterol Hepatol, 2013, 7(2): 141-155. DOI: 10.1586/egh.12.83.
|
[18] |
NARDELLI S, RIGGIO O, GIOIA S, et al. Spontaneous porto-systemic shunts in liver cirrhosis: Clinical and therapeutical aspects[J]. World J Gastroenterol, 2020, 26(15): 1726-1732. DOI: 10.3748/wjg.v26.i15.1726.
|
[19] |
KUMAMOTO M, TOYONAGA A, INOUE H, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: Hepatic deterioration links to portosystemic shunt syndrome[J]. J Gastroenterol Hepatol, 2010, 25(6): 1129-1135. DOI: 10.1111/j.1440-1746.2010.06262.x.
|
[20] |
SAAD WE. Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy[J]. Semin Intervent Radiol, 2014, 31(3): 262-265. DOI: 10.1055/s-0034-1382795.
|
[21] |
SHI Q, WU Z, BAI T, et al. Clinical characteristics analysis of 30 cases of cirrhosis complicated with spontaneous spleen-renal shunt[J]. Chin J Dig, 2017, 37(10): 692-693. DOI: 10.3760/cma.j.issn.0254-1432.2017.10.009.
|
[22] |
LIPINSKI M, SABOROWSKI M, HEIDRICH B, et al. Clinical characteristics of patients with liver cirrhosis and spontaneous portosystemic shunts detected by ultrasound in a tertiary care and transplantation centre[J]. Scand J Gastroenterol, 2018, 53(9): 1107-1113. DOI: 10.1080/00365521.2018.1498913.
|
[23] |
RIGGIO O, EFRATI C, CATALANO C, et al. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: A case-control study[J]. Hepatology, 2005, 42(5): 1158-1165. DOI: 10.1002/hep.20905.
|
[24] |
QI XS, QI XL, ZHANG Y, et al. Prevalence and clinical characteristics of spontaneous splenorenal shunt in liver cirrhosis: A retrospective observational study based on contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) scans[J]. Med Sci Monit, 2017, 23: 2527-2534. DOI: 10.12659/msm.901656.
|
[25] |
ZHAO H, TSAUO J, LI X. Percutaneous retroperitoneal splenorenal shunt: An alternative to transjugular intrahepatic portosystemic shunt?[J]. Am J Transplant, 2016, 16(1): 374. DOI: 10.1111/ajt.13563.
|
[26] |
PHILIPS CA, RAJESH S, GEORGE T, et al. Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy[J]. Indian J Gastroenterol, 2020, 39(4): 377-387. DOI: 10.1007/s12664-020-01042-x.
|
[27] |
ISHIKAWA T, SASAKI R, NISHIMURA T, et al. Improved hepatic reserve and fibrosis in a case of "portal-systemic liver failure" by portosystemic shunt occlusion[J]. Am J Case Rep, 2020, 21: e921236. DOI: 10.12659/AJCR.921236.
|
[28] |
PHILIPS CA, RAJESH S, AUGUSTINE P, et al. Portosystemic shunts and refractory hepatic encephalopathy: Patient selection and current options[J]. Hepat Med, 2019, 11: 23-34. DOI: 10.2147/HMER.S169024.
|
[29] |
CHANG YH, ZHOU XL, JING D, et al. Portal hypertension exacerbates intrahepatic portosystemic venous shunt and further induces refractory hepatic encephalopathy: A case report[J]. World J Clin Cases, 2021, 9(2): 496-501. DOI: 10.12998/wjcc.v9.i2.496.
|
[30] |
HU WY, RAO CY, LIU HB, et al. A case of spontaneous portosystemic shunt with hepatic encephalopathy[J]. J Clin Hepatol, 2019, 35(3): 611-612. DOI: 10.3969/j.issn.1001-5256.2019.03.033.
|
[31] |
TAKAHASHI S, YOSHIDA E, SAKANISHI Y, et al. Congenital multiple intrahepatic portosystemic shunt: An autopsy case[J]. Int J Clin Exp Pathol, 2013, 7(1): 425-431. DOI: 10.7314/APJCP.2014.15.3.1501
|
[32] |
TSOCHATZIS EA, SENZOLO M, GERMANI G, et al. Systematic review: Portal vein thrombosis in cirrhosis[J]. Aliment Pharmacol Ther, 2010, 31(3): 366-374. DOI: 10.1111/j.1365-2036.2009.04182.x.
|
[33] |
European Association for the Study of the Liver. EASL clinical practice guidelines: Vascular diseases of the liver[J]. J Hepatol, 2016, 64(1): 179-202. DOI: 10.1016/j.jhep.2015.07.040.
|
[34] |
GARCÍA-PAGÁN JC, CACA K, BUREAU C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding[J]. N Engl J Med, 2010, 362(25): 2370-2379. DOI: 10.1056/NEJMoa0910102.
|
[35] |
WANG T, LI MS, HAN QR, et al. Analysis of the incidence and prognosis of spontaneous portosystemic shunt in patients with cirrhosis[J]. Chin Hepatol, 2020, 25(9): 948-951. DOI: 10.14000/j.cnki.issn.1008-1704.2020.09.017.
|
[36] |
WAN YM, LI YH, XU ZY, et al. Comparison of TIPS alone and combined with partial splenic embolization (PSE) for the management of variceal bleeding[J]. Eur Radiol, 2019, 29(9): 5032-5041. DOI: 10.1007/s00330-019-06046-6.
|